Physician
Pathology
Dr. David T. Horio, MD
David T. Horio is an expert in the field of Pathology. He attended Harvard Medical School. Harvard Medical School is a top medical college. Harvard Medical School is ranked 1 in research and 12 in primary care medicine David T. Horio, MD is a published MD. He published 8 publications, including: 'Inhibition by chlorophyllin of 2-amino-3-methylimidazo-[4,5-f]quinoline-induced tumorigenesis in the male F344 rat.'
Publications
- Differences in IGF-axis protein expression and survival among multiethnic breast cancer patients.
- Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma.
- Colonic cell proliferation, apoptosis and aberrant crypt foci development in rats given 2-amino-3-methylimidaz.
- beta-Catenin mutation in rat colon tumors initiated by 1,2-dimethylhydrazine and 2-amino-3-methylimidazo[4,5-f]quinoline, and the effect of post-initiation treatment w...
- Post-initiation effects of chlorophyllin and indole-3-carbinol in rats given 1,2-dimethylhydrazine or 2-amino-3-methyl- imidazo.
- Inhibition by chlorophyllin of 2-amino-3-methylimidazo-[4,5-f]quinoline-induced tumorigenesis in the male F344 rat.
- Geminin overexpression induces mammary tumors via suppressing cytokinesis.
Schools
Harvard Medical School
University of Chicago
University HawaiiSt Francis
Doctors Specialties
- Pathology
Accepted Insurances
Education
-
University of Hawaii -
University of Chicago -
Harvard Medical School
Helpful Reviews
Similar Doctors
|
Dr. Eugene T. Yanagihara, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Dana C. Gingell, MD |
|
|
Dr. Ying Cao, MD |
|
|
Dr. Patricia M. Kim, MD
This Doctor is OpenDoctor Recommended.
|